Abstract |
Recent studies demonstrated efficacy of a vitamin/ nutriceutical formulation ( folate, vitamin B12, alpha-tocopherol, S-adenosyl methionine, N-acetyl cysteine, and acetyl-L-carnitine) for mild to moderate Alzheimer's disease. Herein, we tested the efficacy of this formulation in a small cohort of 12 institutionalized patients diagnosed with moderate-stage to later-stage Alzheimer's disease. Participants were randomly separated into treatment of placebo groups. Participants receiving the formulation demonstrated a clinically significant delay in decline in the Dementia Rating Scale and clock-drawing test as compared to those receiving placebo. Institutional caregivers reported approximately 30% improvement in the Neuropyschiatric Inventory and maintenance of performance in the Alzheimer's Disease Cooperative Study- Activities of Daily Living for more than 9 months. This formulation holds promise for delaying the decline in cognition, mood, and daily function that accompanies the progression of Alzheimer's disease, and may be particularly useful as a supplement for pharmacological approaches during later stages of this disorder. A larger trial is warranted.
|
Authors | Ruth Remington, Amy Chan, James Paskavitz, Thomas B Shea |
Journal | American journal of Alzheimer's disease and other dementias
(Am J Alzheimers Dis Other Demen)
2009 Feb-Mar
Vol. 24
Issue 1
Pg. 27-33
ISSN: 1533-3175 [Print] United States |
PMID | 19056706
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Activities of Daily Living
(psychology)
- Affect
(drug effects)
- Aged
- Aged, 80 and over
- Alzheimer Disease
(diagnosis, drug therapy, physiopathology)
- Chemistry, Pharmaceutical
- Cognition
(drug effects)
- Cohort Studies
- Dietary Supplements
- Drug Therapy, Combination
- Humans
- Pilot Projects
- Severity of Illness Index
- Treatment Outcome
- Vitamins
(therapeutic use)
|